Fluoroquinolone-Associated Myasthenia Gravis Exacerbation: Evaluation of Postmarketing Reports from the US FDA Adverse Event Reporting System and a Literature Review

By Jones S. Christopher   Sorbello Alfred   Boucher Robert M.  

Drug Safety, Vol. 34, Iss. 10, 2011-10 ,pp. : 839-847

Adis International

Access to resources Recommend Favorite

Adverse Drug Reactions Related to the Use of Fluoroquinolone Antimicrobials: An Analysis of Spontaneous Reports and Fluoroquinolone Consumption Data from Three Italian Regions

By Leone R.  

Drug Safety, Vol. 26, Iss. 2, 2003-01 ,pp. : 109-120

Adis International

Access to resources Recommend Favorite

Statin-Associated Psychiatric Adverse Events: A Case/Non-Case Evaluation of an Italian Database of Spontaneous Adverse Drug Reaction Reporting

By Tuccori Marco   Lapi Francesco   Testi Arianna  

Drug Safety, Vol. 31, Iss. 12, 2008-01 ,pp. : 1115-1123

Adis International

Access to resources Recommend Favorite

Improving Follow-Up Rates in Spontaneous Adverse Drug Reaction Reporting: Effectiveness of a Targeted Letter Used by a Regional Centre in the UK

By Anton Christopher   Cox Anthony R.   Ferner Robin E.  

Drug Safety, Vol. 32, Iss. 12, 2009-12 ,pp. : 1135-1140

Adis International

Access to resources Recommend Favorite

Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's adverse event reporting system and review of case reports in the literature

By Raisch Dennis W   Garg Vishvas   Arabyat Rasha   Shen Xian   Edwards Beatrice J   Miller Frank H   McKoy June M   Nardone Beatrice   West Dennis P  

Expert Opinion on Drug Safety, Vol. 13, Iss. 1, 2014-01 ,pp. : 15-23

Informa Healthcare

Access to resources Recommend Favorite